Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents

Four cyclometalated iridium(III) complexes containing guanidinium ligands have been synthesized and characterized. These complexes display moderate cytotoxicity by specifically targeting mitochondria and inducing a cascade of apoptotic events related to mitochondrial dysfunction.311